000			01684nam a2200121Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
245		0	_aKilling Cancer _bDiscovery and Selection of New Target Molecules
546			_aEnglish[eng]
650			_aferlin||myoferlin||dysferlin||otoferlin||C2 domain||plasma membrane||sulconazole||NF-κB||IL-8||mammosphere||breast cancer stem cells||AF1Q||MLLT11||WNT||STAT||esophageal cancer||prognosis||mTORC1||mTORC2||metabolism||rapalogs||mTOR inhibitors||cancer metabolism||mTOR in immunotherapy||nutrient metabolism||kinase inhibitors||mTOR signaling||MAPK kinase||ERK1||ERK2||CD domain||Rolled||SCH772984||VRT-11E||sevenmaker||cancer therapy||EMT||lysosome||lysosome-mediated invasion||MZF1||phosphorylation||PAK4||SUMOylation||transcription factor||zinc finger||glucocorticoids||3D growth||nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB)||epithelial–mesenchymal transition||anoikis||proliferation||targeted cancer therapy||disulfiram||NPL4||replication stress||DNA damage||BRCA1||BRCA2||ATR pathway||PDAC||TCIRG1||ATP6V0a3||invasion||migration||matrix degradation||pH-regulation||autophagy||multidrug resistance in cancer||drug efflux pumps||ATP-binding cassette transporter||breast cancer resistance protein (BCRP)||ABCG2||pyrazolo-pyrimidine derivative||SCO-201||colorectal cancer||immunotherapy||inflammation||microsatellite instability||oncofetal chondroitin sulfate||chondroitin sulfate||cancer||solid tumors||target||pediatric cancer||VAR2||dexamethasone||thyroid cancer||microgravity||space environment||n/a
700			_aKallunki, Tuula
856			_uhttps://mdpi.com/books/pdfview/book/3081
942			_cEB
999			_c16266 _d16266